Lawrence D. Kaplan, MD

Clinical Professor of Medicine; Director, Adult Lymphoma Program, Division of Hematology-Oncology, UCSF

Phone: (415) 353-2421
Box 0324, UCSF
San Francisco, CA 94143-0324

View on UCSF Profiles

Additional Websites

• Physician Referral Directory

Education

Brandeis University (Magna cum Laude), BA, 1974, Biology
University of California, Berkeley, MA, 1976, Biochemistry
University of California, Los Angeles, MD, 1980, Medicine

Professional Experience

• 1980-1981
  Medical Intern, Boston City Hospital Department of Medicine
• 1981 1983
  Medical Resident, Boston City Hospital Department of Medicine
• 1983 1985
  Fellow in Hematology and Oncology, University of California San Francisco, Cancer Research Institute
• 1985 1986
  Clinical Instructor in Medicine, University of California, San Francisco, AIDS Program/Oncology Division, San Francisco General Hospital
• 1986-1982
  Assistant Clinical Professor of Medicine, University of California, San Francisco, San Francisco General Hospital, AIDS Program/Oncology Division
• 1992-1998
  Associate Clinical Professor of Medicine, University of California, San Francisco AIDS Program/Oncology Division, San Francisco, San Francisco General Hospital
• 1998-2002
  Clinical Professor of Medicine, University of California, San Francisco, Positive Health Program, San Francisco, San Francisco General Hospital
• 2002- Present
  Clinical Professor of Medicine; Director, Adult Lymphoma Program, Division of Hematology-Oncology, University of California, San Francisco

Honors & Awards

• 7/87-7/90
  American Cancer Society Career Development Award
• 7/91-7/95
  National Cancer Institute RO-1 AIDS-Lymphoma Network Grant, "Novel Therapeutic Approaches for HIV-Associated NHL"
• 1995-present
  National Cancer Institute UO-1 AIDS-Malignancies Consortium

Selected Publications

1. Kaplan LD. Management of HIV-Associated Hodgkin Lymphoma: How Far We Have Come. J Clin Oncol. 2012 Nov 20; 30(33):4056-8.
   View on PubMed
2. Kaplan LD. HIV-associated lymphoma. Best Pract Res Clin Haematol. 2012 Mar; 25(1):101-17.
   View on PubMed
3. Barta SK, Lee JY, Kaplan LD, Noy A, Sparano JA. Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma. Cancer. 2012 Aug 15; 118(16):3977-83.
   View on PubMed
4. Armstrong EJ, Bhave P, Wong D, Ursell PC, Kaplan L, Yeghiazarians Y, Ai WZ. Left ventricular rupture due to HIV-associated T-cell lymphoma. Tex Heart Inst J. 2010; 37(4):457-60.
   View on PubMed
5. Sparano JA, Lee JY, Kaplan LD, Levine AM, Ramos JC, Ambinder RF, Wachsman W, Aboulafia D, Noy A, Henry DH, Von Roenn J, Dezube BJ, Remick SC, Shah MH, Leichman L, Ratner L, Cesarman E, Chadburn A, Mitsuyasu R. Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood. 2010 Apr 15; 115(15):3008-16.
   View on PubMed
6. Chadburn A, Chiu A, Lee JY, Chen X, Hyjek E, Banham AH, Noy A, Kaplan LD, Sparano JA, Bhatia K, Cesarman E. Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. J Clin Oncol. 2009 Oct 20; 27(30):5039-48.
   View on PubMed
7. Lin L, Lee JY, Kaplan LD, Dezube BJ, Noy A, Krown SE, Levine AM, Yu Y, Hayward GS, Ambinder RF. Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood. J Clin Oncol. 2009 May 20; 27(15):2496-502.
   View on PubMed
8. Brinker BT, Krown SE, Lee JY, Cesarman E, Chadburn A, Kaplan LD, Henry DH, Von Roenn JH. Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium. Cancer. 2008 Mar 1; 112(5):1083-8.
   View on PubMed
9. Spitzer TR, Ambinder RF, Lee JY, Kaplan LD, Wachsman W, Straus DJ, Aboulafia DM, Scadden DT. Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020. Biol Blood Marrow Transplant. 2008 Jan; 14(1):59-66.
   View on PubMed
10. Behler CM, Kaplan LD. Advances in the management of HIV-related non-Hodgkin lymphoma. Curr Opin Oncol. 2006 Sep; 18(5):437-43.
    View on PubMed
11. Dunleavy K, Wilson WH, Kaplan LD. The case for rituximab in AIDS-related lymphoma. Blood. 2006 Apr 1; 107(7):3014-5.
    View on PubMed
12. Navarro WH, Kaplan LD. AIDS-related lymphoproliferative disease. Blood. 2006 Jan 1; 107(1):13-20.
    View on PubMed
13. Kaplan LD, Lee JY, Ambinder RF, Sparano JA, Cesarman E, Chadburn A, Levine AM, Scadden DT. Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood. 2005 Sep 1; 106(5):1538-43.
    View on PubMed
14. Michaels MG, Kaufman C, Volberding PA, Gupta P, Switzer WM, Heneine W, Sandstrom P, Kaplan L, Swift P, Damon L, Ildstad ST. Baboon bone-marrow xenotransplant in a patient with advanced HIV disease: case report and 8-year follow-up. Transplantation. 2004 Dec 15; 78(11):1582-9.
    View on PubMed
15. Kaplan LD. Current status of the treatment of HIV-associated lymphoma. Clin Adv Hematol Oncol. 2004 Jan; 2(1):28-9.
    View on PubMed
16. Kaplan LD, Afridi NA, Holmvang G, Zukerberg LR. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 31-2003. A 44-year-old man with HIV infection and a right atrial mass. N Engl J Med. 2003 Oct 2; 349(14):1369-77.
    View on PubMed
17. Gates AE, Kaplan LD. Biology and management of AIDS-associated non-Hodgkin's lymphoma. Hematol Oncol Clin North Am. 2003 Jun; 17(3):821-41.
    View on PubMed
18. Gates AE, Kaplan LD. AIDS malignancies in the era of highly active antiretroviral therapy. Oncology (Williston Park). 2002 May; 16(5):657-65; discussion 665, 668-70.
    View on PubMed
19. Gates AE, Kaplan LD. AIDS malignancies in the era of highly active antiretroviral therapy. Oncology (Williston Park). 2002 Apr; 16(4):441-51, 456, 459.
    View on PubMed
20. Kaplan LD. Fluorine-18 fluorodeoxyglucose positron emission tomography for lymphoma: incorporating new technology into clinical care. Am J Med. 2002 Mar; 112(4):320-1.
    View on PubMed

View on UCSF Profiles